MARMIROLI, Sandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.648
AS - Asia 3.945
EU - Europa 3.836
SA - Sud America 509
AF - Africa 78
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.035
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.577
GB - Regno Unito 1.664
SG - Singapore 1.588
CN - Cina 1.086
HK - Hong Kong 573
IT - Italia 479
BR - Brasile 424
SE - Svezia 424
DE - Germania 320
FI - Finlandia 206
VN - Vietnam 200
UA - Ucraina 188
RU - Federazione Russa 180
TR - Turchia 124
FR - Francia 118
KR - Corea 115
BG - Bulgaria 88
ID - Indonesia 57
IN - India 45
AR - Argentina 35
BE - Belgio 34
MX - Messico 27
IE - Irlanda 25
CA - Canada 24
BD - Bangladesh 22
ZA - Sudafrica 21
AE - Emirati Arabi Uniti 18
JP - Giappone 15
MA - Marocco 15
NL - Olanda 15
EC - Ecuador 14
IR - Iran 13
AT - Austria 12
IQ - Iraq 12
NG - Nigeria 12
AU - Australia 11
CO - Colombia 11
LT - Lituania 11
PK - Pakistan 11
RO - Romania 11
PL - Polonia 9
MY - Malesia 8
QA - Qatar 8
ES - Italia 7
VE - Venezuela 7
CL - Cile 6
PT - Portogallo 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
BO - Bolivia 5
GT - Guatemala 5
NO - Norvegia 5
PH - Filippine 5
RS - Serbia 5
AL - Albania 4
EG - Egitto 4
ET - Etiopia 4
GE - Georgia 4
GR - Grecia 4
KE - Kenya 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HU - Ungheria 3
KW - Kuwait 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
PA - Panama 3
PY - Paraguay 3
TW - Taiwan 3
AM - Armenia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
BZ - Belize 2
CZ - Repubblica Ceca 2
EU - Europa 2
GH - Ghana 2
IL - Israele 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BH - Bahrain 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
Totale 20.020
Salva come PNG Salva come JPEG
Città #
Southend 1.274
Fairfield 1.216
Santa Clara 1.091
Singapore 1.085
Ashburn 837
Woodbridge 734
Hong Kong 569
Houston 536
Chandler 519
Chicago 511
Seattle 477
Wilmington 417
Cambridge 387
Jacksonville 369
Hefei 340
Ann Arbor 327
Dearborn 315
Los Angeles 300
London 223
Nyköping 217
Salt Lake City 196
Beijing 182
San Diego 139
Helsinki 135
Modena 121
Tampa 98
Princeton 90
Sofia 88
Elk Grove Village 86
The Dalles 76
Dallas 73
Seoul 69
Eugene 68
Ho Chi Minh City 68
Moscow 68
Council Bluffs 67
Shanghai 66
New York 64
Izmir 59
Buffalo 58
Des Moines 57
Jakarta 50
Hanoi 44
Bologna 42
Sterling 42
Lancaster 40
Frankfurt am Main 39
Dulles 38
Munich 37
Milan 34
São Paulo 34
Columbus 29
Redwood City 28
San Jose 28
Detroit 27
Phoenix 27
Grafing 26
Miami 25
Dublin 24
Boardman 23
Fremont 22
Ghent 20
Bremen 19
Atlanta 18
Falls Church 18
Pittsburgh 18
Kansas City 16
Norwalk 16
Nuremberg 15
Redondo Beach 14
Rio de Janeiro 14
Rome 14
Tokyo 14
Brussels 13
Dong Ket 13
Guangzhou 13
Brooklyn 12
Jersey City 11
Kent 10
Belo Horizonte 9
Boston 9
Hounslow 9
Nanjing 9
Warsaw 9
Biên Hòa 8
Chiswick 8
Doha 8
Frattamaggiore 8
Johannesburg 8
Karachi 8
Montreal 8
Newark 8
Padova 8
San Francisco 8
Turku 8
Washington 8
Zhengzhou 8
Acton 7
Casablanca 7
Chennai 7
Totale 14.769
Salva come PNG Salva come JPEG
Nome #
The protein kinase Akt/PKB regulates both prelamin A degradation and Lmna gene expression 435
Development of solvent-casting particulate leaching (SCPL) polymer scaffolds as improved three-dimensional supports to mimic the bone marrow niche 432
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas 401
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 389
MATER protein as substrate of PKCepsilon in human cumulus cells. 386
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit 379
Human MATER localization in specific cell domains of oocytes and follicular cells 375
Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins 364
Targeting of the Akt/PKB kinase to the actin skeleton 350
Risk Assessment for Metals and PAHs by Mediterranean Seafood 345
Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level 342
Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells 335
Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase 332
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 327
The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines 319
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer 319
Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and Function 309
Troglitazione affects survival of human osteosarcoma cells 306
Lamin A Ser404 Is a Nuclear Target of Akt Phosphorylation in C2C12 Cells 304
Inhibition of phosphoinositide 3-kinase impairs pre-commitment cell cycle traverse and prevents differentiation in erythroleukaemia cells. 298
Phosphorylation, Signaling, and Cancer: Targets and Targeting 294
Nuclear Nox4 interaction with prelamin A is associated with nuclear redox control of stem cell aging 292
Ankrd2/ARPP is a novel Akt2 specific substrate andregulates myogenic differentiation upon cellular exposure to H(2)O(2). 291
Cross-talk between the CK2 and AKT signaling pathways in cancer 290
AKT1-mediated Lamin A/C degradation is required for nuclear degradation and normal epidermal terminal differentiation 286
Serum fatty acids and risk of cutaneous melanoma: a population-based case-control study 284
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 283
Association of emerin with nuclear and cytoplasmic actin is regulated in differentiating myoblasts 272
A-type lamins and signaling: the PI 3-kinase/Akt pathway moves forward 271
Rapamycin treatment of Mandibuloacral dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamics 268
Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target? 266
Phosphatidylinositol 3-kinase translocation to the nucleus is induced by interleukin 1 and prevented by mutation of interleukin 1 receptor in human osteosarcoma Saos-2 cells 265
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 261
Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria. 256
Phosphatidylinositol 3-kinase is required for the induction of ornithine decarboxylase in leukemia cells stimulated to growth. 253
Inhibition of Ras-mediated signaling pathways in CML stem cells 243
The need for a reassessment of the safe upper limit of selenium in drinking water 240
Reverse-phase protein microarrays (RPPA) as a diagnosticand therapeutic guide in multidrug resistant leukemia 238
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 235
Nuclear PLCβ1 acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells 232
Melanocytes – A novel tool to study mitochondrial dysfunction in Duchenne Muscular Dystrophy 227
Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity inBoth p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibitingthe Akt Pathway 226
Nuclear damages and oxidative stress: new perspectives for laminopathies 225
Nuclear lipid-dependent signal transduction in human osteosarcoma cells. 224
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS. 223
Signaling specificity in the Akt pathway in biology and disease 217
Phosphatidylinositol 3-kinase translocation to the nucleus is an early event in the interleukin-1 signalling mechanism in human osteosarcoma Saos-2 cells. 215
Environmental risk factors for amyotrophic lateral sclerosis: methodological issues in epidemiologic studies 215
The Oral PKC-ß Inhibitor Enzastaurin (LY317615) Suppress Phosphorylation and Induces Apoptosis in Multiple Myeloma Cell Lines by Inhibition of AKT Pathway. 215
Tiazofurin induces a down modulation of ICAM-1 expression on K562 target cells impairing NK adhesion and killing. 214
Laminopathies and A-type lamin-associated signalling pathways 214
New roles for lamins, nuclear envelope proteins and actin in the nucleus 212
At the nucleus of the problem: Nuclear proteins and disease 212
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer 212
Clusterin enhances migration and invasion of prostate cancer cells through an isoform-specific Akt2/miR-190/PHLPP1 circuit. 207
Phosphoinositidase C isozymes in SaOS-2 cells: immunocytochemical detection in nuclear and cytoplasmic compartments. 207
Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy 203
Age-related events in human active T limphocytes. Changes in the phosphoinositidase C activity. 199
Nuclear protein kinases in rat liver: evidence for increased Histone H1 phosphorylating activity during liver regeneration. 197
Influence of selenium on the emergence of neuro tubule defects in a neuron-like cell line and its implications for amyotrophic lateral sclerosis 194
Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I. 193
Protein kinase B/AKT isoform 2 drives migration of human mesenchymal stem cells. 192
Inhibition of the expression of ornithine decarboxylase and c-Myc by cell-permeant ceramide in difluoromethylornithine-resistant leukaemia cells. 181
The intranuclear amount of phospholipase C beta1 decreases following cell differentiation in Friend cells, whereas gamma1 isoform is not affected. 161
An unbiased approach to mapping the signaling network of the pseudorabies virus US3 protein 153
Interleukin-1alfa stimulates nuclear phosphoinositidase C activity in human osteosarcoma SaOS-2 cells. 149
Transfected Saos-2 cells overexpressing phosphoinositidase C beta1 isoform accumulate it within the nucleus. 147
Unusual laminin alpha2 processing in myoblasts from a patient with a novel variant of congenital muscular dystrophy. 147
Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence. 140
The key role of public health in renovating Italian biomedical doctoral programs 138
Interleukin-1-receptor-associated kinase 2 (IRAK2)-mediated interleukin-1-dependent nuclear factor kappa B transactivation in Saos2 cells requires the Akt/protein kinase B kinase 133
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells 131
Editorial: Special Issue on Innovative Multi-Disciplinary Approaches for Precision Studies in Leukemia 130
A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival 128
Mechanisms involved in the promoting activity of fibroblasts in HTLV-1-mediated lymphomagenesis: Insights into the plasticity of lymphomatous cells 116
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells 111
Stabilization of ornithine decarboxylase in erythroleukemia cells depleted of ATP 100
A different involvement of polyamines in the induction of tyrosine aminotransferase by glucagon, isoproterenol or serum in cultured heart cells 99
Editor's Note: Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity in Both p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibiting the Akt Pathway 93
Effect of ATP depletion and phenanthroline on the spermidine-mediated decay of ornithine decarboxylase in erythroleukemia cells 93
Effect of sodium arsentie on the induction and turnover of ornithine decarboxylase activity in erythroleukemia cells 86
IL-1 receptor signalling mechanism in SAOS-2 osteosarcoma cells 85
Involvement of thiol transferase- and thioredoxin-dependent systems in the protection of 'essential' thiol groups of ornithine decarboxylase 85
Phosphorylation of ornithine decarboxylase in intact erythroleukemia cells 82
Immunocytochemical detection of the specific association of different PIC isoforms with cytoskeletal and nuclear matrix compartments in PC12 cells 79
Study on the role of endogenous polyamines in glucagon, isoproterenol or serum-mediated induction of tyrosine aminotransferase in cultured heart cells 78
Inositol lipid phosphorylation and breakdown in rat liver nuclei is affected by hydrocortisone blood levels 77
Critical role of protein kinase CK2 in chronic myeloid leukemia cells harboring the T315I BCR::ABL1 mutation 74
Regulation of hormonal sensitivity of cardiac cells in culture by polyamines 73
Inhibition of rat heart ornithine decarboxylase by basic polypeptides 73
Totale 20.152
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.394
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.356 0 0 0 0 0 177 169 252 93 367 191 107
2021/20221.889 72 227 223 147 28 83 128 119 144 124 435 159
2022/20231.498 180 150 133 121 158 231 34 153 211 5 64 58
2023/20241.052 37 45 54 128 212 77 148 133 43 27 36 112
2024/20253.680 97 35 48 208 764 625 182 239 396 178 408 500
2025/20265.024 429 244 460 1.175 2.186 530 0 0 0 0 0 0
Totale 20.152